Transpact Enterprises Limited Share Price & Stock Analysis

Transpact Enterprises Limited (BSE: 542765) is a Mumbai, Maharashtra-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹0 Cr, it ranks #6,118 by market cap among the 6,197 Indian listed companies on FinBizNet, and #13 of 13 in Pharmaceutical Product Distribution. At ₹105.70 (as of 16 Nov 2026), the share price is 55.0% below its 52-week high of ₹234.90 and 29.7% above its 52-week low of ₹81.47. The share price is down 50.4% over one year and up 11.3% over three months.

Key Metrics

Current Price₹105.70
Market Cap₹0 Cr
BSE Code542765
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Distributors > Pharmaceutical Product Distribution
P/E Ratio48.4
Return on Assets6.80%
52-Week Range₹81.47 – ₹234.90
1-Year Price Change-50.4%
3-Month Price Change+11.3%
Beta (1Y)-0.28
HeadquartersMumbai, Maharashtra
Websitetranspact.in

Shareholding and Delivery

Delivery averaged 96.3% of traded volume across 6 BSE sessions (26 Oct 2026 – 13 Nov 2026).

About Transpact Enterprises Limited

Transpact Enterprises Limited provides consulting and advisory services for corporate, financial, and commercial matters in India. The company offers management consulting, debt structuring, debt advisory, project appraisals, and other services by any person, corporate, firm, and association. It is also involved in dealing in shares, securities, commodities, currencies and derivatives, stock and share broker, sub-broker, authorized person, dealer, jobber, market maker, investment brokers, insurance broker, underwriter, and brokerage services. Transpact Enterprises Limited was incorporated in 2013 and is based in Mumbai, India.

Products and Services

1. Medical Products-This segment engages in the design, development, manufacturing, and distribution of therapeutic devices. It also provides rehabilitations services with analytics and management software system. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Medical Products-100%

Transpact Enterprises Limited vs Peers — Pharmaceutical Product Distribution

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Entero Healthcare Solutions Limited₹8,733 Cr74.68.28%₹2,087 Cr+80.7%
Remus Pharmaceuticals Limited₹941 Cr26.113.78%—+0.6%
Health X Platform Limited (Sastasundar Ventures Ltd)₹871 Cr752.7-0.18%₹484 Cr-5.7%
Aptus Pharma Limited₹837 Cr156.8——+754.0%
Vasa Denticity Limited₹797 Cr76.56.68%₹87 Cr-21.4%
Bijoy Hans Ltd₹523 Cr———+128.4%
Speciality Medicines Limited₹149 Cr11.5———
Vijaypd Ceutical Limited₹136 Cr239.53%——
Transpact Enterprises Limited₹0 Cr48.4——-50.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Transpact Enterprises Limited?

Transpact Enterprises Limited is trading at ₹105.70, with a market capitalisation of ₹0 Cr.

Which sector does Transpact Enterprises Limited belong to?

Transpact Enterprises Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).

What are the key financial ratios of Transpact Enterprises Limited?

Transpact Enterprises Limited has a P/E of 48.4.

What is the stock symbol of Transpact Enterprises Limited?

Transpact Enterprises Limited is listed on the BSE under the scrip code 542765.

How has Transpact Enterprises Limited's share price moved over the past year?

Transpact Enterprises Limited's share price is down 50.4% over one year and up 11.3% over three months. Its 52-week range is ₹81.47 to ₹234.90.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.